Sara DeshpandeinMaven Ventures$60M Maven Fund IV: Fresh Capital to Lead the Next DecadeMaven’s latest fund will continue a successful track record of investing in tech companies addressing emerging consumer trendsApr 16Apr 16
Sara DeshpandeinMaven VenturesInvesting in Medeloop: AI and the Future of Clinical ResearchMaven Ventures joins General Catalyst to invest in Medeloop, a Stanford-founded AI startup improving the clinical research process.Oct 5, 20231Oct 5, 20231
Sara DeshpandeinMaven VenturesPowering Generosity Through Our Investment in PledgeWith Pledge, every Zoom call, Clubhouse chat, Shopify store, and virtual event can become a fundraising opportunity for non-profits.Mar 17, 2021Mar 17, 2021
Sara DeshpandeinMaven VenturesFour Levers to Optimize your Funding RoundToo many founders optimize their fundraising based on a single metric: valuation. Of course, I understand where this comes from, and the…Feb 5, 2019Feb 5, 2019
Sara DeshpandeinMaven VenturesGetting Investor Attention: Seven Steps to a Verbal Pitch that WorksThere’s a lot of great information available about investor presentations, pitch decks, and the fundraising process. But many entrepreneurs…Apr 4, 2018Apr 4, 2018
Sara DeshpandeinStartups & Venture CapitalMaven Investment Themes: Where We’re Putting our Money NowOur investment thesis at Maven is to identify emerging consumer trends and invest in software technology that transforms millions of lives…Dec 14, 20171Dec 14, 20171
Sara DeshpandeinMaven VenturesRequired Reading for Aspiring VCsAs the level of interest in starting and joining early-stage tech companies grows, so does interest in funding them. Usually once a week or…Apr 27, 201712Apr 27, 201712
Sara DeshpandeinMaven VenturesWhat’s the next billion dollar digital health idea?I’ve spent the last year and a half meeting healthcare startup founders. About six months ago, I wrote about several challenges in consumer…Feb 14, 2017Feb 14, 2017
Sara DeshpandeinMaven VenturesLessons from Inside Six Startup ExitsThe most popular topic in tech might be the coveted “exit.” We read about them every day — whether the pace is speeding or slowing, which…Nov 17, 20163Nov 17, 20163
Sara DeshpandeThree Reasons I Haven’t Invested in Consumer Health — YetIt’s an exciting time to be an investor in consumer healthcare companies. Before becoming a VC, I was a management consultant focused on…Aug 25, 20163Aug 25, 20163
